Pre-earnings brief
Reports
Wed, Oct 21, 2026
Est. EPS
$1.91
Est. revenue
$6.6B
Implied move
±8.7%
EPS beat rate
88%
Danaher Corporation (DHR) operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in providing innovative solutions that support research and diagnostics, making it significant in the ongoing advancements in health care technology.
Last quarter
In Q2 2026, Danaher reported an EPS of $1.94, exceeding expectations by 5.72%. However, the stock fell by nearly 11% the following day, indicating market concerns despite the earnings beat.
EPS beat streak
6Q
EPS beat rate
88%
Avg EPS surprise
+7.11%
Avg 1-day reaction
-2.40%
Analysts expect Danaher to report solid earnings, with a consensus EPS of $1.91 and revenue of $6.6 billion. The market is particularly focused on whether the company can maintain its growth trajectory amidst economic uncertainties.
Bull case
If Danaher beats EPS estimates and shows strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.
Bear case
Conversely, if the company misses estimates or provides weak guidance, it may raise concerns about its future growth prospects, resulting in a negative stock reaction.
Key metrics to watch
EPS
1.91Earnings per share is a key indicator of profitability and is closely watched by investors.
Revenue
6.6BTotal revenue reflects the company's ability to generate sales and is critical for assessing growth.
The print will turn on these.
Q1
Will Danaher achieve an EPS of at least $1.91?
This number is critical as it sets the tone for investor confidence and future growth expectations.
Q2
What guidance will management provide for revenue growth?
Investors will closely monitor this to gauge the company's outlook in the current economic environment.
—
Est. EPS
$0.24
Est. Rev
$5.7B
Impl. Move
±13.0%
Why consensus could be wrong
The consensus may underestimate the potential for Danaher to exceed revenue expectations due to strong demand in its life sciences segment.
Supporting evidence
Danaher has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.
The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news.
The recent decline in stock price following earnings beats may indicate a market underestimating the company's resilience.
Key risk
If revenue growth significantly outpaces expectations, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is debating Danaher's ability to sustain growth amidst economic pressures, making these thresholds critical.
Bull confirmed if
An EPS of $1.95 or higher, coupled with revenue exceeding $6.7 billion, would confirm the bullish case.
Bear confirmed if
An EPS below $1.83 or revenue below $6.4 billion would confirm the bearish case.
What the market is pricing for the move.
Implied Move
±8.69%
Historical Avg
±5.1%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±8.7% while DHR has averaged ±5.1% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
28.7%
Smart-money positioning from the most recent 13F filings.
Institutional
84.41%
of float
Insider
10.96%
of float
Holders
2,859
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
55,084,630 sh · $12.0B
7.84%
6.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Danaher beats expectations, history suggests the stock could rise by approximately 3.1% on the first trading day.
In line / cautious
If results are in line with expectations but management is cautious, the stock may react neutrally or slightly down.
Miss
A miss could lead to a decline of around 9.73%, reflecting investor disappointment.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
0 buys·1 sell
Members
1
House only
Est. Notional
$15,001.00–$50,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
41,377,076 sh · $9.0B
5.89%
0.6%
FMR, LLC
29,540,895 sh · $6.5B
4.20%
31.1%
State Street Corporation
28,456,019 sh · $6.2B
4.05%
2.0%
Wellington Management Group, LLP
16,316,834 sh · $3.6B
2.32%
10.4%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Aug 31, 2026 · disclosed Sep 25, 2026
$15,001.00–$50,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.